Medtronic plc
MDT
Rank in Stocks
#183
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Share Price
$94.70
Last synced: 2026-10-16
Market Cap
$121.14B
Change (1 day)
-1.36%
Change (1 year)
-1.13%
Country
IE
Trade Medtronic plc (MDT)
Category
Healthcare
EPS for Medtronic plc (MDT)
EPS as of January 2026 TTM: $3.59
According to Medtronic plc latest financial reports and stock price the company's current EPS (TTM) is $3.59. At the end of 2024 the company had a EPS of $2.77 a decrease compared to its 2023 EPS that were of $2.83.
EPS history for Medtronic plc from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $3.59 | -1.10% |
| 2025 | $3.63 | 31.05% |
| 2024 | $2.77 | -2.12% |
| 2023 | $2.83 | -24.53% |
| 2022 | $3.75 | 39.93% |
| 2021 | $2.68 | -24.93% |
| 2020 | $3.57 | 3.78% |
| 2019 | $3.44 | 50.22% |
| 2018 | $2.29 | -21.58% |
| 2017 | $2.92 | 16.33% |
| 2016 | $2.51 | 2.87% |
| 2015 | $2.44 | -20.26% |
| 2014 | $3.06 | -10.00% |
| 2013 | $3.40 | -0.87% |
| 2012 | $3.43 | 19.51% |
| 2011 | $2.87 | 2.50% |
| 2010 | $2.80 | 51.35% |
| 2009 | $1.85 | -6.09% |
| 2008 | $1.97 | -19.26% |
| 2007 | $2.44 | 15.64% |
| 2006 | $2.11 | 41.61% |
| 2005 | $1.49 | -7.45% |
| 2004 | $1.61 | 22.90% |
| 2003 | $1.31 | 61.73% |
| 2002 | $0.81 | -6.90% |
| 2001 | $0.87 | -4.40% |
| 2000 | $0.91 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.11 | -13.37% |
US
|
|
| $9.73 | 171.03% |
US
|
|
| $2.48 | -30.92% |
US
|
|
| - | - |
DE
|
|
| $1.74 | -51.53% |
US
|
